Literature DB >> 19149568

Immune-glutamatergic dysfunction as a central mechanism of the autism spectrum disorders.

R L Blaylock1, A Strunecka.   

Abstract

Despite the great number of observations being made concerning cellular and the molecular dysfunctions associated with autism spectrum disorders (ASD), the basic central mechanism of these disorders has not been proposed in the major scientific literature. Our review brings evidence that most heterogeneous symptoms of ASD have a common set of events closely connected with dysregulation of glutamatergic neurotransmission in the brain with enhancement of excitatory receptor function by pro-inflammatory immune cytokines as the underlying mechanism. We suggest that environmental and dietary excitotoxins, mercury, fluoride, and aluminum can exacerbate the pathological and clinical problems by worsening excitotoxicity and by microglial priming. In addition, each has effects on cell signaling that can affect neurodevelopment and neuronal function. Our hypothesis opens the door to a number of new treatment modes, including the nutritional factors that naturally reduce excitotoxicity and brain inflammation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19149568     DOI: 10.2174/092986709787002745

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  39 in total

Review 1.  Staging perspectives in neurodevelopmental aspects of neuropsychiatry: agents, phases and ages at expression.

Authors:  Trevor Archer; Richard M Kostrzewa; Richard J Beninger; Tomas Palomo
Journal:  Neurotox Res       Date:  2010-03-17       Impact factor: 3.911

2.  In vivo 1H-magnetic resonance spectroscopy study of the attentional networks in autism.

Authors:  Silvia Bernardi; Evdokia Anagnostou; Jun Shen; Alexander Kolevzon; Joseph D Buxbaum; Eric Hollander; Patrick R Hof; Jin Fan
Journal:  Brain Res       Date:  2010-12-23       Impact factor: 3.252

Review 3.  Schizophrenia and autism: both shared and disorder-specific pathogenesis via perinatal inflammation?

Authors:  Urs Meyer; Joram Feldon; Olaf Dammann
Journal:  Pediatr Res       Date:  2011-05       Impact factor: 3.756

4.  Reply to letter of Peter Good.

Authors:  Martha R Herbert
Journal:  Neuropsychol Rev       Date:  2011-01-19       Impact factor: 7.444

5.  Distinct plasma profile of polar neutral amino acids, leucine, and glutamate in children with Autism Spectrum Disorders.

Authors:  Rabindra Tirouvanziam; Tetyana V Obukhanych; Julie Laval; Pavel A Aronov; Robin Libove; Arpita Goswami Banerjee; Karen J Parker; Ruth O'Hara; Leonard A Herzenberg; Leonore A Herzenberg; Antonio Y Hardan
Journal:  J Autism Dev Disord       Date:  2012-05

Review 6.  Environmental factors associated with autism spectrum disorder: a scoping review for the years 2003-2013.

Authors:  M Ng; J G de Montigny; M Ofner; M T Do
Journal:  Health Promot Chronic Dis Prev Can       Date:  2017-01       Impact factor: 3.240

Review 7.  Beyond infection - Maternal immune activation by environmental factors, microglial development, and relevance for autism spectrum disorders.

Authors:  Staci D Bilbo; Carina L Block; Jessica L Bolton; Richa Hanamsagar; Phuong K Tran
Journal:  Exp Neurol       Date:  2017-07-08       Impact factor: 5.330

8.  Riluzole as an adjunctive therapy to risperidone for the treatment of irritability in children with autistic disorder: a double-blind, placebo-controlled, randomized trial.

Authors:  Ali Ghaleiha; Effat Mohammadi; Mohammad-Reza Mohammadi; Mehdi Farokhnia; Amirhossein Modabbernia; Habibeh Yekehtaz; Mandana Ashrafi; Elmira Hassanzadeh; Shahin Akhondzadeh
Journal:  Paediatr Drugs       Date:  2013-12       Impact factor: 3.022

9.  Impaired lipid metabolism markers to assess the risk of neuroinflammation in autism spectrum disorder.

Authors:  Hanan Qasem; Laila Al-Ayadhi; Geir Bjørklund; Salvatore Chirumbolo; Afaf El-Ansary
Journal:  Metab Brain Dis       Date:  2018-03-22       Impact factor: 3.584

10.  Efficacy of DMSA Therapy in a Sample of Arab Children with Autistic Spectrum Disorder.

Authors:  Eleonor Blaucok-Busch; Omnia R Amin; Hani H Dessoki; Thanaa Rabah
Journal:  Maedica (Buchar)       Date:  2012-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.